Based on the application, the global digital pathology market is broadly segmented into disease diagnosis; teleconsultation; drug discovery; and education & training. The teleconsultation application segment is estimated to account for the largest share of the global digital pathology market in 2016. Additionally, this segment is projected to grow at the highest CAGR.
On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World( RoW). In 2016, North America is estimated to account for the largest share of the global digital pathology market, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is slated to grow at the highest CAGR and serve as a revenue pocket for companies offering digital pathology.
Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH( Germany), Ventana Medical Systems, Inc.( U. S.), Hamamatsu Photonics K. K( Japan), 3D Histech Ltd.( Hungary), Philips Healthcare( Netherlands), Apollo Enterprise Imaging Corp.( U. S.), Xifin, Inc.( U. S.), Definiens AG( Germany), Visiopharm A / S( Denmark), Omnyx LLC( U. S.), Corista LLC( U. S.).
Download Sample Brochure